SNS-01

N/A

Report date: 2024/11/15 20:00:35

Base Information

Drug NameSNS-01
Drug Alias NameeIF5A siRN A/eIF5AK50R pDNA PEIPEI:peIF5A(K50R):h5A1nanocomplexesSNS-01-TSNS-01 +[6] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionEukaryotic translation initiation factor 5A inhibitorsApoptosis stimulantsRNA interference
TargetsEukaryotic translation initiation factor 5A
Therapy Area/IndicationsMultiple MyelomaLymphoma, Large B-Cell, DiffuseLeukemia, Plasma Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Africa
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEloxx PharmaceuticalsSenesco Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSenesco Technologies Inc
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaLymphoma, Large B-Cell, DiffuseLeukemia, Plasma Cell

Other Information

ATC CodeN/A
Related LinksN/A